Viewing nowRovasta Tablet 5 Milligrams (Rosuvastatin Calcium)
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

MFDS item code 201403561 · Approved 2014.07.31 · Insurance code 644308800
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medicine is primarily used as an adjunct therapy when diet and exercise alone are insufficient to control primary hypercholesterolemia and mixed hyperlipidemia patients. It is also effective as an adjunct to diet or other lipid-lowering therapies in patients with homozygous familial hypercholesterolemia. In patients with hypercholesterolemia, it helps lower total cholesterol and LDL cholesterol levels to target levels, delaying the progression of atherosclerosis. Moreover, it is used as an adjunct therapy to reduce total cholesterol, LDL cholesterol, and Apo-B levels in pediatric patients aged 10 to 17 years who meet specific criteria. Additionally, it can be utilized as an adjunct to diet in patients with primary dysbetalipoproteinemia. Finally, it helps reduce the risk of stroke, myocardial infarction, and arterial revascularization in certain high-risk patients, aiding in the prevention of cardiovascular disease. In summary, this medicine is effectively used for the treatment of various forms of hyperlipidemia and the reduction of cardiovascular disease risk.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug and continue it throughout the treatment period. This drug may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, the treatment goal, and the patient's response; the dose may be increased up to a maximum of 20 milligrams once daily. 3. Older adults: No dosage adjustment is necessary. 4. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering this drug at a dose of 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. 6. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.
This medication should not be administered to certain patients. For example, individuals allergic to the components of this medication or those with severely impaired liver function should not take it. Additionally, it should not be used by individuals with muscle disorders, severely impaired kidney function, pregnant or breastfeeding women, and women of childbearing age who do not practice appropriate contraception. \n\nCaution should be exercised when using this medication in patients at high risk for myopathy or rhabdomyolysis, and high-dose administration is contraindicated. This medication contains lactose, so those with lactose intolerance should not take it. \n\nFor patients who consume alcohol excessively or have a history of liver disease, liver function tests should be conducted multiple times before initiating this medication. If a patient has conditions such as hypothyroidism or nephrotic syndrome, the underlying condition should be treated before using this medication. \n\nDuring treatment, if symptoms such as muscle pain, muscle weakness, or muscle cramps occur, the doctor should be informed immediately, and a blood test should be conducted. Notably, if muscle enzyme levels rise significantly, the medication should be discontinued. \n\nThis medication may temporarily raise liver enzyme levels; therefore, liver function tests may be necessary. Rarely, skin rashes, urticaria, and severe skin reactions may occur, so if symptoms arise, discontinuation and consultation with a physician are necessary. \n\nThis medication may interact with other drugs, leading to increased blood concentrations of this medication and a heightened risk of muscle damage if taken concurrently with certain drugs. Thus, any concomitant medications should be disclosed to a physician or pharmacist. \n\nPregnant or breastfeeding women should not take this medication, and women who could become pregnant should use safe contraception methods. \n\nIn case of overdose, there is no specific antidote; treatment should be based on symptoms, and careful monitoring of liver function and muscle enzyme levels is necessary. \n\nThis medication may cause dizziness; therefore, caution is needed when driving or operating machinery. \n\nFinally, children and adolescents can also use this medication, but careful monitoring of their growth and developmental status is necessary.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular muscle weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lichen planus-like drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, fatigue, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, muscle spasms
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. Furthermore, it should be kept at room temperature, ideally between 1 to 30 degrees Celsius, where it is not excessively high or low.
Yellow, convex round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.